Analysis of Stuyvesant Capital Management's Q3-Q4 2018 Holdings Comparison
Ava Hoppe | 19 April, 2023
Stuyvesant Capital Management has made significant changes in their holdings between Q3 2018 and Q4 2018, according to the 13F Holdings Comparison released by the company. The report indicates the changes in the number of shares held by the company as well as the value of those shares. The following is a detailed analysis of some of the notable changes in the company’s holdings.
PFE:
Pfizer Inc., a pharmaceutical company, saw a decrease of 45.1% in the number of shares held by Stuyvesant Capital Management. In Q3 2018, the company held 134,725 shares, which reduced to 74,720 shares in Q4 2018. The value of the shares also decreased from $5,937,000 to $3,262,000 in the same period.
VIAB:
Stuyvesant Capital Management also reduced its holdings of Viacom Inc. by 31.7%. The company held 122,410 shares in Q3 2018, which decreased to 109,850 shares in Q4 2018. The value of the shares held by the company has also reduced from $4,133,000 to $2,823,000.
FCX:
Freeport-McMoRan Inc., a mining company, saw Stuyvesant Capital Management reduce its holdings by 31.7%. The company held 252,700 shares in Q3 2018, which reduced to 233,125 shares in Q4 2018. The value of the shares also decreased from $3,518,000 to $2,404,000.
AIG:
Stuyvesant Capital Management also reduced its holdings of American International Group Inc. by 40.4%. The company held 51,989 shares in Q3 2018, which reduced to 41,834 shares in Q4 2018. The value of the shares also decreased from $2,768,000 to $1,649,000.
PCAR:
PACCAR Inc., a truck manufacturing company, saw Stuyvesant Capital Management increase its holdings by 550.2%. The company held 3,450 shares in Q3 2018, which increased to 26,750 shares in Q4 2018. The value of the shares also increased from $235,000 to $1,528,000.
CHK:
Stuyvesant Capital Management reduced its holdings of Chesapeake Energy Corp. by 55.5%. The company held 709,160 shares in Q3 2018, which reduced to 674,330 shares in Q4 2018. The value of the shares also decreased from $3,184,000 to $1,416,000.
GE:
General Electric Co. saw Stuyvesant Capital Management reduce its holdings by 38.5%. The company held 186,725 shares in Q3 2018, which reduced to 171,375 shares in Q4 2018. The value of the shares also decreased from $2,108,000 to $1,297,000.
EWZ:
Stuyvesant Capital Management increased its holdings of iShares Inc. – MSCI Brazil ETF by 7.4%. The company held 20,350 shares in Q3 2018, which increased to 19,300 shares in Q4 2018. The value of the shares also increased from $686,000 to $737,000.
CXDC:
China XD Plastics Co. Ltd. saw Stuyvesant Capital Management reduce its holdings by 56.7%. The company held 151,869 shares in Q3 2018, which reduced to 134,669 shares in Q4 2018. The value of the shares also decreased from $547,000 to $237,000.
EWP:
iShares Inc. – MSCI Spain ETF saw Stuyvesant Capital Management sell off all its holdings in Q4 2018 after holding 10,825 shares in Q3 2018. The value of the shares was $321,000 in Q3 2018.
Conclusion:
Stuyvesant Capital Management made some significant changes in their holdings between Q3 2018 and Q4 2018. While some companies saw a decrease in the numbers of shares held by the company, others saw an increase. The changes in the number of shares held were also reflected in the value, with some shareholders seeing a decrease in the value of their shares, and others experiencing an increase.
Other Posts
- Investing in Infrastructure: Compass Group's Partnership with Anderson UnderBridge
- Auxilior Term Funding 2023-1: A New Opportunity for Investors
- AWH Capital's Q4 2022 Filing Reveals Significant Shifts in Portfolio Allocation, Including Bet on Infrastructure and Skincare Industries.
- Tributary Capital Management, LLC-Q3 2023 vs. Q4 2023 13F Holdings Comparison
- Revving Up the Midwest: How Fenix Parts' Latest Acquisition Fuels Expansion Dreams
- 13F Holding Comparison: Denali Advisors LLC Q4 2022 vs. Q1 2023
- Congress Park Capital LLC Q3 2023 vs. Q4 2023 13F Holdings Comparison
- D'Orazio & Associates, Inc. Q2 2023 vs. Q3 2023: A Comprehensive Analysis of 13F Holdings
- **Unlocking Potential: Navidea Biopharmaceuticals and CRG Settle Ongoing Litigation**
- Dean Investment Associates, LLC: A Q3 2022 vs. Q4 2022 13F Holdings Comparison